WallStSmart
PBYI

Puma Biotechnology Inc

NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY

$7.48
-0.80% today

Updated 2026-04-29

Market cap
$382.08M
P/E ratio
12.31
P/S ratio
1.67x
EPS (TTM)
$0.61
Dividend yield
52W range
$3 – $8
Volume
0.4M

Puma Biotechnology Inc (PBYI) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-15.09M$-11834.00$-16815.00$-18246.00$-1.83M$-44.00M$-55.05M$-77.20M$-154.50M$-141.70M$-172.50M$-24.10M$22.38M$800000.00$20.65M$-15.83M$27.01M$38.92M$41.80M
Capital expenditures$0.00$0.00$0.00$0.00$692755.00$1.06M$628000.00$1.29M$1.18M$7.28M$50.43M$609000.00$306000.00$20.05M$1000.00$7.00M$12.64M$56000.00$71000.00
Depreciation
Stock-based comp$1.41M$7.52M$39.15M$94.93M$117.26M$108.73M$86.94M$57.33M$36.58M$32.63M$11.83M$10.25M$8.24M$6.94M
Free cash flow$-15.09M$-11834.00$-16815.00$-18246.00$-2.52M$-45.06M$-55.68M$-78.49M$-155.68M$-148.98M$-222.93M$-24.71M$22.07M$-19.25M$20.65M$-22.83M$14.37M$38.86M$41.73M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$53.38M$84.03M$-94.36M$-4.50M$-6.97M$162.93M$-112.80M$26.72M$-39.53M$24.24M$-22.16M$3.50M